Literature DB >> 19211567

Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

Hany Abdel-Hafiz1, Michelle L Dudevoir, Kathryn B Horwitz.   

Abstract

Posttranslational modification by small ubiquitin-like modifier (SUMO) is a major regulator of transcription. We previously showed that progesterone receptors (PR) have a single consensus psiKXE SUMO-conjugation motif centered at Lys-388 in the N-terminal domain of PR-B and a homologous site of PR-A. SUMOylation of the PR is hormone-dependent and has a suppressive effect on transcription of an exogenous promoter. Here we show that repression of PR activity by SUMOylation at Lys-388 is uncoupled from phosphorylation, involves synergy between tandem progesterone response elements, and is associated with lowered ligand sensitivity and slowed ligand-dependent down-regulation. However, paradoxically, cellular overexpression of SUMO-1 increases PR transcriptional activity even if Lys-388 is mutated, suggesting that the receptors are activated indirectly by other SUMOylated proteins. One of these is the coactivator SRC-1, whose binding to PR and enhancement of agonist-dependent N-/C-terminal interactions is augmented by the presence of SUMO-1. Increased transcription due to SRC-1 is independent of PR SUMOylation based on assays with the Lys-388 mutants and the pure antiprogestin ZK98299, which blocks N-/C-terminal interactions. In summary, SUMOylation tightly regulates the transcriptional activity of PR by repressing the receptors directly while activating them indirectly through augmented SRC-1 coactivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211567      PMCID: PMC2666559          DOI: 10.1074/jbc.M805226200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.

Authors:  M Tirard; O F X Almeida; P Hutzler; F Melchior; T M Michaelidis
Journal:  Mol Cell Endocrinol       Date:  2007-01-25       Impact factor: 4.102

2.  Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors.

Authors:  Dongqing Wang; Qi Wang; Smita Awasthi; S Stoney Simons
Journal:  Biochemistry       Date:  2007-06-16       Impact factor: 3.162

Review 3.  SUMO and NF-kappaB ties.

Authors:  A M Mabb; S Miyamoto
Journal:  Cell Mol Life Sci       Date:  2007-08       Impact factor: 9.261

4.  A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.

Authors:  Kevin P Madauss; Eugene T Grygielko; Su-Jun Deng; Anthony C Sulpizio; Thomas B Stanley; Charlene Wu; Steve A Short; Scott K Thompson; Eugene L Stewart; Nicholas J Laping; Shawn P Williams; Jeffrey D Bray
Journal:  Mol Endocrinol       Date:  2007-03-13

5.  Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.

Authors:  Andrea R Daniel; Emily J Faivre; Carol A Lange
Journal:  Mol Endocrinol       Date:  2007-08-23

Review 6.  SUMO: getting it on.

Authors:  J Anckar; L Sistonen
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

Review 7.  Progesterone receptor isoforms in normal and malignant breast.

Authors:  P A Mote; J D Graham; C L Clarke
Journal:  Ernst Schering Found Symp Proc       Date:  2007

Review 8.  Regulation of SRC family coactivators by post-translational modifications.

Authors:  Shaosi Li; Yongfeng Shang
Journal:  Cell Signal       Date:  2007-02-20       Impact factor: 4.315

9.  Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.

Authors:  Alicia Subtil-Rodríguez; Lluís Millán-Ariño; Ignacio Quiles; Cecilia Ballaré; Miguel Beato; Albert Jordan
Journal:  Mol Cell Biol       Date:  2008-03-31       Impact factor: 4.272

10.  CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.

Authors:  Pei-Jing Zhang; Jie Zhao; Hui-Yan Li; Jiang-Hong Man; Kun He; Tao Zhou; Xin Pan; Ai-Ling Li; Wei-Li Gong; Bao-Feng Jin; Qing Xia; Ming Yu; Bei-Fen Shen; Xue-Min Zhang
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

View more
  18 in total

1.  Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding.

Authors:  Raj Kumar; Carmen M Moure; Shagufta H Khan; Celetta Callaway; Sandra L Grimm; Devrishi Goswami; Patrick R Griffin; Dean P Edwards
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

2.  Differential and interactive effects of ligand-bound progesterone receptor A and B isoforms on tyrosine hydroxylase promoter activity.

Authors:  P J Jensik; L A Arbogast
Journal:  J Neuroendocrinol       Date:  2011-10       Impact factor: 3.627

Review 3.  Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.

Authors:  Margeaux Wetendorf; Francesco J DeMayo
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 4.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

5.  Lysine methylation of progesterone receptor at activation function 1 regulates both ligand-independent activity and ligand sensitivity of the receptor.

Authors:  Hwa Hwa Chung; Siu Kwan Sze; Amanda Rui En Woo; Yang Sun; Kae Hwan Sim; Xue Ming Dong; Valerie C-L Lin
Journal:  J Biol Chem       Date:  2014-01-10       Impact factor: 5.157

Review 6.  Post-translational modifications of the progesterone receptors.

Authors:  Hany A Abdel-Hafiz; Kathryn B Horwitz
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-12       Impact factor: 4.292

Review 7.  Progesterone: the ultimate endometrial tumor suppressor.

Authors:  Shujie Yang; Kristina W Thiel; Kimberly K Leslie
Journal:  Trends Endocrinol Metab       Date:  2011-02-25       Impact factor: 12.015

Review 8.  Structural and functional analysis of domains of the progesterone receptor.

Authors:  Krista K Hill; Sarah C Roemer; Mair E A Churchill; Dean P Edwards
Journal:  Mol Cell Endocrinol       Date:  2011-07-22       Impact factor: 4.102

Review 9.  Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation.

Authors:  Robert D Ward; Nancy L Weigel
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

10.  Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.

Authors:  Caroline H Diep; Todd P Knutson; Carol A Lange
Journal:  Mol Cancer Res       Date:  2015-11-17       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.